437 related articles for article (PubMed ID: 30915506)
1. CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.
Kwak MK; Lee EJ; Park JW; Park SY; Kim B-; Kim TH; Suh K; Koh J-; Lee SH; Byun D-
Osteoporos Int; 2019 Jul; 30(7):1501-1510. PubMed ID: 30915506
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of reduced bone mineral density in primary HIV-1-infected men.
Grijsen ML; Vrouenraets SM; Steingrover R; Lips P; Reiss P; Wit FW; Prins JM
AIDS; 2010 Sep; 24(14):2233-8. PubMed ID: 20616695
[TBL] [Abstract][Full Text] [Related]
3. Long-term HIV infection and antiretroviral therapy are associated with bone microstructure alterations in premenopausal women.
Calmy A; Chevalley T; Delhumeau C; Toutous-Trellu L; Spycher-Elbes R; Ratib O; Zawadynski S; Rizzoli R
Osteoporos Int; 2013 Jun; 24(6):1843-52. PubMed ID: 23138338
[TBL] [Abstract][Full Text] [Related]
4. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
[TBL] [Abstract][Full Text] [Related]
5. Continuous antiretroviral therapy decreases bone mineral density.
Grund B; Peng G; Gibert CL; Hoy JF; Isaksson RL; Shlay JC; Martinez E; Reiss P; Visnegarwala F; Carr AD;
AIDS; 2009 Jul; 23(12):1519-29. PubMed ID: 19531929
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
Carr A; Grund B; Neuhaus J; Schwartz A; Bernardino JI; White D; Badel-Faesen S; Avihingsanon A; Ensrud K; Hoy J;
HIV Med; 2015 Apr; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
[TBL] [Abstract][Full Text] [Related]
7. Bone mass, body composition and vitamin D status of ARV-naïve, urban, black South African women with HIV infection, stratified by CD₄ count.
Hamill MM; Ward KA; Pettifor JM; Norris SA; Prentice A
Osteoporos Int; 2013 Nov; 24(11):2855-61. PubMed ID: 23719859
[TBL] [Abstract][Full Text] [Related]
8. Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection.
Porcelli T; Gotti D; Cristiano A; Maffezzoni F; Mazziotti G; Focà E; Castelli F; Giustina A; Quiros-Roldan E
Osteoporos Int; 2014 Sep; 25(9):2263-9. PubMed ID: 25056799
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral-naïve HIV-infected patients had lower bone formation markers than HIV-uninfected adults.
Wattanachanya L; Jantrapakde J; Avihingsanon A; Ramautarsing R; Kerr S; Trachunthong D; Pussadee K; Teeratakulpisarn N; Jadwattanakul T; Chaiwatanarat T; Buranasupkajorn P; Phanuphak N; Sunthornyothin S; Phanuphak P;
AIDS Care; 2020 Aug; 32(8):984-993. PubMed ID: 31137948
[TBL] [Abstract][Full Text] [Related]
10. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.
Bruera D; Luna N; David DO; Bergoglio LM; Zamudio J
AIDS; 2003 Sep; 17(13):1917-23. PubMed ID: 12960824
[TBL] [Abstract][Full Text] [Related]
11. The rate of bone loss slows after 1-2 years of initial antiretroviral therapy: final results of the Strategic Timing of Antiretroviral Therapy (START) bone mineral density substudy.
Carr A; Grund B; Schwartz AV; Avihingsanon A; Badal-Faesen S; Bernadino JI; Estrada V; La Rosa A; Mallon P; Pujari S; White D; Wyman Engen N; Ensrud K; Hoy JF;
HIV Med; 2020 Jan; 21(1):64-70. PubMed ID: 31642586
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Stable Bone Mineral Density in HIV-Infected Men Without Risk Factors for Osteoporosis Treated with Antiretroviral Therapy.
Bolland MJ; Horne AM; Briggs SE; Thomas MG; Reid IR; Gamble GD; Grey A
Calcif Tissue Int; 2019 Oct; 105(4):423-429. PubMed ID: 31250043
[TBL] [Abstract][Full Text] [Related]
13. Relative contribution of HIV infection, demographics and body mass index to bone mineral density.
Cotter AG; Sabin CA; Simelane S; Macken A; Kavanagh E; Brady JJ; McCarthy G; Compston J; Mallon PW;
AIDS; 2014 Sep; 28(14):2051-60. PubMed ID: 25265073
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of bone mineral density changes in aging men with or at risk for HIV infection.
Sharma A; Flom PL; Weedon J; Klein RS
AIDS; 2010 Sep; 24(15):2337-45. PubMed ID: 20683316
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study.
Han WM; Wattanachanya L; Apornpong T; Jantrapakde J; Avihingsanon A; Kerr SJ; Teeratakulpisarn N; Jadwattanakul T; Chaiwatanarat T; Buranasupkajorn P; Ramautarsing R; Phanuphak N; Sunthornyothin S; Ruxrungtham K; Phanuphak P;
PLoS One; 2020; 15(3):e0230368. PubMed ID: 32210458
[TBL] [Abstract][Full Text] [Related]
16. Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection.
Vlot MC; Grijsen ML; Prins JM; de Jongh RT; de Jonge R; den Heijer M; Heijboer AC
PLoS One; 2018; 13(3):e0193679. PubMed ID: 29522570
[TBL] [Abstract][Full Text] [Related]
17. Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected Mediterranean subjects.
Li Vecchi V; Soresi M; Giannitrapani L; Mazzola G; La Sala S; Tramuto F; Caruso G; Colomba C; Mansueto P; Madonia S; Montalto G; Di Carlo P
BMC Infect Dis; 2012 Aug; 12():192. PubMed ID: 22894751
[TBL] [Abstract][Full Text] [Related]
18. Unravelling hip-spine bone mineral density discordance in people living with HIV.
Vizcarra P; Rosillo M; Del Rey JM; Moreno A; Vivancos MJ; Casado JL
J Bone Miner Metab; 2022 Nov; 40(6):990-997. PubMed ID: 36038672
[TBL] [Abstract][Full Text] [Related]
19. Effect of Testosterone Use on Bone Mineral Density in HIV-Infected Men.
Grant PM; Li X; Jacobson LP; Palella FJ; Kingsley LA; Margolick JB; Dobs AS; Lake JE; Althoff KN; Brown TT
AIDS Res Hum Retroviruses; 2019 Jan; 35(1):75-80. PubMed ID: 30280921
[TBL] [Abstract][Full Text] [Related]
20. Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection.
Arnsten JH; Freeman R; Howard AA; Floris-Moore M; Lo Y; Klein RS
AIDS; 2007 Mar; 21(5):617-23. PubMed ID: 17314524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
